专利检索 ap:("GENELABS TECHNOLOGIES, INC.") AND inv:"GURWITH, Marc, J." 第 1 页

1.

发明公开
TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) WITH DEHYDROEPIANDROSTERONE 审中-公开
标题翻译：治疗系统性红斑狼疮（SLE）与脱氢表雄酮

公开(公告)号：EP1231924A2

公开(公告)日：2002-08-21

申请号：EP00980257.0

申请日：2000-11-13

申请人： GENELABS TECHNOLOGIES, INC.

发明人： SCHWARTZ, Kenneth, E. , GURWITH, Marc, J.

IPC分类号： A61K31/5685 , A61P37/00 , A61P5/26

CPC分类号： A61K31/5685 , A61K45/06 , A61K2300/00

摘要： This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.

2.

发明公开
PHARMACEUTICAL COMPOSITION COMPRISING POLYMORPHIC FORMS OF DEHYDROEPIANDROSTERONE 审中-公开
标题翻译：脱氢表雄酮的药物组合物多晶型晶体形式含有

公开(公告)号：EP1778246A2

公开(公告)日：2007-05-02

申请号：EP00916432.8

申请日：2000-03-16

申请人： GENELABS TECHNOLOGIES, INC.

发明人： PARASRAMPURIA, Jagdish , YONKER, Maxine, B. , SCHWARTZ, Kenneth, E. , GURWITH, Marc, J.

IPC分类号： A61K31/5685 , A61P19/10 , A61P37/00 , A61P21/00

CPC分类号： A61K31/5685

摘要： Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.